Trading FDA, Clinical Trial Binary Events: MarketGuru.com Site Closing
The following alert was posted today on the social / virtual investing site at MarketGuru.com regarding the site being closed down by the end of the month…
…MarketGuru was founded in January of 2008 and like many other companies, we were hit with the world financial crisis which made it difficult to find investors for our project…Our real frustration is our complete faith that social investing works. We KNOW that MarketGuru makes investors better and this knowledge makes it that much more difficult to give up and abandon ship. We should be around till the end of the month or so. Best wishes to you all.
Below is a chart of my final performance statistics at MarketGuru.com / mikehavRx compared to the Dow Jones Industrial Average and NASDAQ Composite Index since I began using the site in December 2008, with the strongest results posted year-to-date in 2010 that include a gain in excess of 130% based on a focused strategy of small / micro-cap bio-pharma stocks and utilizing the research included in the daily Regulatory Catalyst Index updates.

I am currently considering several options to provide a low-cost and simple way for people to invest in the 18 HavRx Stock Indexes, including potential exchange-traded fund (ETF) licensing deals, Investars YOU personalized stock index investing, and Folio Investing as a Registered Investment Advisor (RIA). Stay tuned to the site for more details on any or all of these options. In the meantime, the subscriber home page has been completely revamped along with several new features for members such as a daily Regulatory Catalyst Watch List report, forum, etc. described in this overview article.
www.mikehavRx.com is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 591 entries and 385 companies (including approximately 200 stocks trading under $5 per share and 40 private companies). Promo codes (50% discount) are available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services.

By Mike Havrilla on 06/16/2010 4:00 pm PST -- Biotech